Anne H. Cross

31.7k citations

253 papers · 20.3k indexed · 5 hit papers · h-index 71

Impact in

Pathology and Forensic Medicine top 0.05%
- Multiple Sclerosis Research Studies
Radiology, Nuclear Medicine and Imaging top 0.05%
- Advanced Neuroimaging Techniques and Applications
- Advanced MRI Techniques and Applications

Papers in

Pathology and Forensic Medicine 145
- Multiple Sclerosis Research Studies 143
Immunology 80
- Immunotherapy and Immune Responses 33
- T-cell and B-cell Immunology 23

Co-authors: Sheng‐Kwei Song Shu‐Wei Sun John H. Russell Michael J. Ramsbottom Robert T. Naismith Laura Piccio Kathryn Trinkaus Cedric S. Raine
Journals: Neurology (32 papers)Journal of Neuroimmunology (30 papers)Multiple Sclerosis Journal (20 papers)Multiple Sclerosis and Related Disorders (15 papers)NeuroImage (12 papers)
Partner nations: United States Italy Germany

In The Last Decade

Anne H. Cross

251 papers receiving 20.0k citations

Hit Papers

5 papers align trajectories log scale

Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis 2021 · 181 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 JAMA Neurology
2018 Cell Metabolism
2005 NeuroImage
2003 NeuroImage
2002 NeuroImage

Peers

Countries citing papers authored by Anne H. Cross

Since Specialization

Citations

This map shows the geographic impact of Anne H. Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne H. Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne H. Cross more than expected).

Fields of papers citing papers by Anne H. Cross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne H. Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne H. Cross. The network helps show where Anne H. Cross may publish in the future.

Co-authors

The 25 scholars most cited alongside Anne H. Cross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anne H. Cross Line = papers co-authored together Anne H. Cross links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A single-cell compendium of human cerebrospinal fluid identifies disease-associated immune cell populations Journal of Clinical Investigation ·Claudia Cantoni, Margarita Smirnov, Maria Firulyova, Prabhakar S. Andhey, Tara R. Bradstreet, Ekaterina Esaulova, М. В. Терехова, Elizabeth A. Schwarzkopf, Nada M. Abdalla, Maksim Kleverov, Joseph J. Sabatino, Kang Liu, Nicholas Schwab, Gerd Meyer zu Hörste, Anne H. Cross, Maxim N. Artyomov, Brian T. Edelson, Gregory F. Wu	2025	3
2	376 Pathophysiology of voluntary motor commands in patients with multiple sclerosis identified using reverse engineering of motor unit population discharge. Journal of Clinical and Translational Science ·Laura McPherson, Tanner M. Reece, Skyler Simon, Keith R. Lohse, Francesco Negro, Catherine E. Lang, Robert T. Naismith, Anne H. Cross	2024	1
3	Functional outcomes of diets in multiple sclerosis (FOOD for MS): Protocol for a parallel arm randomized feeding trial for low glycemic load and calorie restriction Contemporary Clinical Trials ·Kat Martin, Stacey S. Cofield, Anne H. Cross, Amy M. Goss, Cyrus A. Raji, John R. Rinker, Gregory F. Wu, Jessica Blair, Anja Fuchs, Laura Ghezzi, Kathryn Green, Francesca Pace, Giovanni Pastori, Meghan G. Taylor, Laura Piccio, Brooks C. Wingo	2024	2
4	Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials The Lancet Neurology ·Xavier Montalbán, Patrick Vermersch, Douglas L. Arnold, Amit Bar‐Or, Bruce Cree, Anne H. Cross, Eva Havrdová, Ludwig Kappos, Olaf Stüve, Heinz Wiendl, Jerry S. Wolinsky, Frank Dahlke, Claire Le Bolay, Li Shen Loo, Sathej Gopalakrishnan, Yann Hyvert, Andrija Javor, Hans Guehring, Nadia Tenenbaum, Davorka Tomic, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2024	32
5	Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients Annals of Neurology ·Matthew R. Brier, Suzanne E. Schindler, Amber Salter, Dana C. Perantie, Nicole Shelley, Bradley Judge, Sarah Keefe, Kristopher M. Kirmess, Philip B. Verghese, Kevin E. Yarasheski, Venky Venkatesh, Cyrus A. Raji, Brian A. Gordon, Randall J. Bateman, John C. Morris, Robert T. Naismith, David M. Holtzman, Tammie L.S. Benzinger, Anne H. Cross	2024	5
6	Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion Neurologic Clinics ·Afsaneh Shirani, Olaf Stüve, Anne H. Cross	2023	1
7	Quantitative Analysis of S1PR1 Expression in the Postmortem Multiple Sclerosis Central Nervous System ACS Chemical Neuroscience ·Hao Jiang, Charles Zhou, Lin Qiu, Robert J. Gropler, Matthew R. Brier, Gregory F. Wu, Anne H. Cross, Joel S. Perlmutter, Tammie L.S. Benzinger, Zhude Tu	2023	1
8	Humoral immune response to COVID-19 mRNA vaccines in patients with relapsing multiple sclerosis treated with ofatumumab Multiple Sclerosis and Related Disorders ·Amit Bar‐Or, Rany Aburashed, Ángel Chinea, Barry Hendin, Elisabeth B. Lucassen, Xiangyi Meng, James Stankiewicz, Mark Tullman, Anne H. Cross	2023	3
9	Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial Multiple Sclerosis and Related Disorders ·Mitzi Williams, Annette F. Okai, Anne H. Cross, Nancy Monson, Timothy Vartanian, Ben Thrower, Anthony T. Reder, Jeffrey B English, Gregory F. Wu, Evanthia Bernitsas, Shereen Yap, Jugena Ndrio, Jinglan Pei, Ellen M. Mowry, Fabio Magrini, Juan Acosta, Lilyana Amezcua	2023	8
10	Schwann Cell Remyelination in the Multiple Sclerosis Central Nervous System Laboratory Investigation ·Laura Ghezzi, Bryan Bollman, Luca De Feo, Laura Piccio, Bruce D. Trapp, Robert E. Schmidt, Anne H. Cross	2023	6
11	Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS Multiple Sclerosis Journal ·Biao Xiang, Matthew R. Brier, Manasa Kanthamneni, Jie Wen, Abraham Z. Snyder, Dmitriy A. Yablonskiy, Anne H. Cross	2022	3
12	Stronger Microstructural Damage Revealed in Multiple Sclerosis Lesions With Central Vein Sign by Quantitative Gradient Echo MRI SHILAP Revista de lepidopterología ·Victoria A. Levasseur, Biao Xiang, Amber Salter, Dmitriy A. Yablonskiy, Anne H. Cross	2022	3
13	Effects of dietary restriction on neuroinflammation in neurodegenerative diseases The Journal of Experimental Medicine ·Luigi Fontana, Laura Ghezzi, Anne H. Cross, Laura Piccio	2021	66
14	In Vitro and In Vivo Investigation of S1PR1 Expression in the Central Nervous System Using [³H]CS1P1 and [¹¹C]CS1P1 ACS Chemical Neuroscience ·Hao Jiang, Sumit Joshi, Hui Liu, Syahir Mansor, Lin Qiu, Haiyang Zhao, Timothy Whitehead, Robert J. Gropler, Gregory F. Wu, Anne H. Cross, Tammie L.S. Benzinger, Kooresh I. Shoghi, Joel S. Perlmutter, Zhude Tu	2021	19
15	Alterations of the gut mycobiome in patients with MS EBioMedicine ·Saumya Shah, Alberto Locca, Yair Dorsett, Claudia Cantoni, Laura Ghezzi, Qingqi Lin, Suresh Bokoliya, Hunter Panier, Cassandra Suther, Matthew Gormley, Yue Liu, Emily Evans, Robert Mikesell, Kathleen A. Obert, Amber Salter, Anne H. Cross, Phillip I. Tarr, Amy E. Lovett‐Racke, Laura Piccio, Yanjiao Zhou	2021	53
16	COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America Neurology Neuroimmunology & Neuroinflammation ·Scott D. Newsome, Anne H. Cross, Robert J. Fox, June Halper, Pamela Kanellis, Bruce F. Bebo, David Li, Gary Cutter, Kottil Rammohan, Amber Salter	2021	12
17	Axonal transport rate decreased at the onset of optic neuritis in EAE mice NeuroImage ·Tsen‐Hsuan Lin, Joong Hee Kim, Carlos J. Pérez‐Torres, Chia‐Wen Chiang, Kathryn Trinkaus, Anne H. Cross, Sheng‐Kwei Song	2014	35
18	ITAM signaling in dendritic cells controls T helper cell priming by regulating MHC class II recycling Blood ·Daniel B. Graham, Holly M. Akilesh, Grzegorz B. Gmyrek, Laura Piccio, Susan Gilfillan, Julia Sim, Roger Belizaire, Javier A. Carrero, Yinan Wang, Gregory S. Blaufuss, Gabriel J. Sandoval, Keiko Fujikawa, Anne H. Cross, John H. Russell, Marina Cella, Wojciech Swat	2010	15
19	Pathological Expression of CXCL12 at the Blood-Brain Barrier Correlates with Severity of Multiple Sclerosis American Journal Of Pathology ·Erin E. McCandless, Laura Piccio, B. Mark Woerner, Robert E. Schmidt, Joshua B. Rubin, Anne H. Cross, Robyn S. Klein	2008	158
20	Cell interactions and receptor antibodies in immune responses : proceedings of the third Sigrid Jusélius symposium Academic Press eBooks ·O. Mäkelä, Anne H. Cross, T Kosunen, Sigrid Jusélius stiftelse	1971	6

About Anne H. Cross

Anne H. Cross is a scholar working on Pathology and Forensic Medicine, Immunology, Neurology, Radiology, Nuclear Medicine and Imaging and Neurology, having authored 253 papers that have together received 20.3k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (143 papers), Advanced Neuroimaging Techniques and Applications (41 papers), Peripheral Neuropathies and Disorders (34 papers), Immunotherapy and Immune Responses (33 papers), Neuroinflammation and Neurodegeneration Mechanisms (27 papers), Systemic Lupus Erythematosus Research (25 papers), T-cell and B-cell Immunology (23 papers) and Monoclonal and Polyclonal Antibodies Research (20 papers). The work is most often cited by research in Pathology and Forensic Medicine (6.6k citations), Radiology, Nuclear Medicine and Imaging (8.0k citations), Neurology (2.6k citations), Developmental Neuroscience (925 citations) and Neurology (3.3k citations). Anne H. Cross has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Sheng‐Kwei Song, Shu‐Wei Sun, John H. Russell, Michael J. Ramsbottom, Robert T. Naismith, Laura Piccio, Kathryn Trinkaus, Cedric S. Raine, Chen Chang and Jeri‐Anne Lyons. Their work appears in journals such as Neurology, Journal of Neuroimmunology, Multiple Sclerosis Journal, Multiple Sclerosis and Related Disorders and NeuroImage.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact